Figure 6.
![Figure 6. The effect of anti-Bcl-2-scFv-TAT treatment on cell survival. Primary culture of BMMCs (A) and RBL cells (B) were treated with various concentrations of scFvs-TAT (untreated cells [□], anti-Bcl-2-scFv-TAT [▪], nonspecific scFv-TAT [▦]). The viability of the cells was assessed by trypan blue exclusion (mean ± SE; n = 3).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/102/7/10.1182_blood-2002-12-3921/6/h81935002006.jpeg?Expires=1724237544&Signature=hHlNzrHo0asJz-bogYNs3VttgT2MByHK5gVhQX3dv9QXY6O3zs3s4dQOwq-~IWW-Xe9AUsXbIqrTkcY0tjicRx3zkh1pW2aqyQULnubTiUsiwy1V1Rrjn~Dk87O83hHX3kUAHRqX8ncnskcWXMsOghS9gWedqJIiIjjrRi-QFaybq3LQ4AD8f5NO8LnDwM3nUsWB4B5VRtyI5KsXiHUaEBt0A3D6~6~ukg7S7EZm375Ekx9N4PLqIhqyEbSNZniUcRxwp~TpTFunS378Jx4EZhQnaqpCMvdaFzTjOJUD9mztwqY3IIoZVUuT1Zb8dI1HkHMBPqODsDYmOgtZwVX3hw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
The effect of anti-Bcl-2-scFv-TAT treatment on cell survival. Primary culture of BMMCs (A) and RBL cells (B) were treated with various concentrations of scFvs-TAT (untreated cells [□], anti-Bcl-2-scFv-TAT [▪], nonspecific scFv-TAT [▦]). The viability of the cells was assessed by trypan blue exclusion (mean ± SE; n = 3).
